• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物从微晶纤维素微丸系统中的释放机制。

Drug release mechanism from a microcrystalline cellulose pellet system.

作者信息

O'Connor R E, Schwartz J B

机构信息

Department of Pharmaceutics, School of Pharmacy, Philadelphia College of Pharmacy & Science, Pennsylvania 19104.

出版信息

Pharm Res. 1993 Mar;10(3):356-61. doi: 10.1023/a:1018928003668.

DOI:10.1023/a:1018928003668
PMID:8464807
Abstract

A common form of modified release is the encapsulation of specially formulated or coated pellets. An important first step in the development of a multiparticulate coated dosage form is to characterize the uncoated pellet. In earlier work, an uncoated pellet system developed in these laboratories and prepared from microcrystalline cellulose (MCC) was investigated and found to exhibit both the physical characteristics of an inert matrix and varying degrees of in vitro modified release. The use and characterization of MCC as a spheronization matrix material forms the basis for this formulation study. The drug release mechanism has been verified by varying selected formulation factors and evaluating the resulting pellets according to the relationship developed by T. Higuchi for granular inert matrices. In all cases, this MCC pellet system adhered to the theoretical relationships and the drug release mechanism can, therefore, be classified as an inert matrix.

摘要

一种常见的缓释形式是对特殊配方或包衣的小丸进行封装。开发多颗粒包衣剂型的重要第一步是对未包衣小丸进行表征。在早期工作中,对在这些实验室开发并由微晶纤维素(MCC)制备的未包衣小丸系统进行了研究,发现其既具有惰性基质的物理特性,又具有不同程度的体外缓释特性。使用MCC作为滚圆基质材料并对其进行表征,构成了本制剂研究的基础。通过改变选定的制剂因素,并根据T. Higuchi为颗粒状惰性基质建立的关系评估所得小丸,药物释放机制得到了验证。在所有情况下,这种MCC小丸系统都符合理论关系,因此药物释放机制可归类为惰性基质。

相似文献

1
Drug release mechanism from a microcrystalline cellulose pellet system.药物从微晶纤维素微丸系统中的释放机制。
Pharm Res. 1993 Mar;10(3):356-61. doi: 10.1023/a:1018928003668.
2
Drug release from a multiparticulate pellet system.
Pharm Dev Technol. 1996 Apr;1(1):37-42. doi: 10.3109/10837459609031416.
3
A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.微晶纤维素物理特性对挤出滚圆法成型性能影响的研究
Pharm Res. 2001 Apr;18(4):480-7. doi: 10.1023/a:1011054310895.
4
Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.采用挤出滚圆法制备雷尼替丁微丸,微晶纤维素用量极少或不用。
Pharm Dev Technol. 1999;4(4):499-505. doi: 10.1081/pdt-100101387.
5
Influence of MCC II fraction and storage conditions on pellet properties.MCC II 级分和储存条件对颗粒性质的影响。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1039-45. doi: 10.1016/j.ejpb.2013.07.001. Epub 2013 Jul 17.
6
Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.κ-卡拉胶丸剂作为缓控释多颗粒片剂的配方的适用性。
Int J Pharm. 2011 May 16;409(1-2):9-18. doi: 10.1016/j.ijpharm.2011.02.016. Epub 2011 Feb 16.
7
Approaches to developing fast release pellets via wet extrusion-spheronization.通过湿挤压造粒法开发快速释放丸剂的方法。
Pharm Dev Technol. 2018 Jun;23(5):432-441. doi: 10.1080/10837450.2016.1265556. Epub 2016 Dec 9.
8
In vitro behavior of dronedarone hydrochloride loaded pellets using vacuum impregnation technique.采用真空浸渍技术研究盐酸多非利特微丸的体外行为。
Eur J Pharm Biopharm. 2021 May;162:70-81. doi: 10.1016/j.ejpb.2021.03.003. Epub 2021 Mar 14.
9
Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.微晶纤维素-乳糖-卡波姆片剂及微晶纤维素-磷酸二钙-卡波姆微丸的干燥对其微观结构和药物释放曲线的影响
Eur J Pharm Biopharm. 2008 Jun;69(2):675-85. doi: 10.1016/j.ejpb.2007.11.016. Epub 2007 Dec 5.
10
Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.壳聚糖-海藻酸盐作为微晶纤维素在挤出/滚圆法中替代制粒助剂的应用。
J Pharm Sci. 2007 Sep;96(9):2469-84. doi: 10.1002/jps.20855.

引用本文的文献

1
Design, Synthesis, Evaluation, and Molecular Docking Study of Ascorbic Acid Dual-Coated Omeprazole Pellets and the Antioxidative Effect of Ascorbic Acid on Omeprazole-Induced Renal Injury in an Animal Model.抗坏血酸双包衣奥美拉唑微丸的设计、合成、评价及分子对接研究以及抗坏血酸对动物模型中奥美拉唑诱导的肾损伤的抗氧化作用
ACS Omega. 2023 Dec 19;9(1):1143-1155. doi: 10.1021/acsomega.3c07396. eCollection 2024 Jan 9.
2
Release behaviour of single pellets and internal fine 3D structural features co-define the in vitro drug release profile.单颗粒的释放行为和内部精细的三维结构特征共同决定了体外药物释放曲线。
AAPS J. 2014 Jul;16(4):860-71. doi: 10.1208/s12248-014-9611-x. Epub 2014 May 30.
3
The use of nanocrystalline cellulose for the binding and controlled release of drugs.
纳米纤维素在药物结合和控制释放中的应用。
Int J Nanomedicine. 2011;6:321-30. doi: 10.2147/IJN.S16749. Epub 2011 Feb 10.
4
Ketotifen controlled release from cellulose acetate propionate and cellulose acetate butyrate membranes.酮替芬从醋酸丙酸纤维素和醋酸丁酸纤维素膜中的控释。
J Mater Sci Mater Med. 2008 Feb;19(2):677-82. doi: 10.1007/s10856-007-0168-4. Epub 2007 Jul 10.
5
The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization.微晶纤维素在湿法制粒、挤出和滚圆过程中的微晶-凝胶模型。
Pharm Res. 1997 Jun;14(6):804-9. doi: 10.1023/a:1012166809583.